An observational study in Malignant Neoplasms of Independent (Primary) Multiple Sites, sponsored by M.D. Anderson Cancer Center. Withdrawn. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2019-05-22.
Sponsored by M.D. Anderson Cancer Center · Observational
Objectives:
Primary Objective:
The primary objective is to identify the difference in the estimation of prognosis of advanced cancer patients between medical oncologists, gynecological oncologists, and palliative care physicians
The goal of this research study is to identify the difference in the estimation of prognosis of advanced cancer patients between medical or gynecological oncologists, and palliative care physicians. Up to 140 patients will be enrolled in this study.
M.D. Anderson Cancer Center is the lead sponsor of 3,044 studies on the registry; 578 are open to participants now.
Of its 608 completed or terminated interventional studies of FDA-regulated products, 407 (67%) have results posted.
Counted across the registry records on this site, refreshed daily.
Medical oncologists and palliative care physicians from UT MD Anderson Cancer Center
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
N/A
Medical oncology physicians are sent the Estimation of Prognosis questionnaire by email.
Behavioral: Estimation of Prognosis Questionnaire
Palliative care physicians are sent the Estimation of Prognosis questionnaire by email.
Behavioral: Estimation of Prognosis Questionnaire
Survey will examine two aspects of prognosis estimation: 1.) physician factors, 2.) prognosis estimation and contributing factors to patient prognosis. Survey will take approximately 5 minutes to complete.
Also known as: Survey
Estimation of Patient Overall Survival by Oncologists and by Palliative Care Physicians per Estimation of Prognosis Questionnaire
The answer to the question #4, "How long do you think this patient will live?" in the questionnaire is the primary endpoint. Denoting the oncologist estimated OS time from the day of palliative care consult to death by TOnc, palliative care physician estimate by TPalliative, and the true OS time by T0, we define the accuracy of the estimation of OS by oncologists and by palliative care physician as ΔOnc = TOnc - T0 ΔPalliative = TPalliative - T0. And the difference between these two estimates is calculated as ΔOS = ΔOnc - ΔPalliative. Based on the above formulas, ΔOS is actually calculated as (TOnc- TPalliative). The true survival time, T0, is cancelled out by the subtraction.
Time frame: 6 weeks
No study locations are listed for this record.
This study is withdrawn, as verified in May 2019. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.